288 related articles for article (PubMed ID: 31997106)
1. Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?
De Bruyn C; Baert T; Van den Bosch T; Coosemans A
Curr Oncol Rep; 2020 Jan; 22(2):12. PubMed ID: 31997106
[TBL] [Abstract][Full Text] [Related]
2. Circulating Protein Biomarkers to Differentiate Uterine Sarcomas from Leiomyomas.
Glorie N; Baert T; VAN DEN Bosch T; Coosemans AN
Anticancer Res; 2019 Aug; 39(8):3981-3989. PubMed ID: 31366479
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract][Full Text] [Related]
4. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
Muinelo-Romay L; Casas-Arozamena C; Abal M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors.
Hadjimichael AC; Pergaris A; Kaspiris A; Foukas AF; Theocharis SE
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768955
[TBL] [Abstract][Full Text] [Related]
6. The utility of preoperative endometrial sampling for the detection of uterine sarcomas.
Bansal N; Herzog TJ; Burke W; Cohen CJ; Wright JD
Gynecol Oncol; 2008 Jul; 110(1):43-8. PubMed ID: 18445505
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of liquid biopsy in endometrial carcinoma.
Shen Y; Shi R; Zhao R; Wang H
Med Oncol; 2023 Feb; 40(3):92. PubMed ID: 36757457
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating tumour cells may add value in endometrial cancer management.
Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
[TBL] [Abstract][Full Text] [Related]
10. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorská D; Škovierová H; Braný D; Halašová E; Danková Z
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387281
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
13. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
15. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
16. Vascular invasion in uterine sarcomas and its significance. A multi-institutional study.
Roma AA; Barbuto DA; Samimi SA; Stolnicu S; Alvarado-Cabrero I; Chanona-Vilchis J; Aguilera-Barrantes I; de Peralta-Venturina M; Malpica A; Rutgers JK; Silva EG
Hum Pathol; 2015 Nov; 46(11):1712-21. PubMed ID: 26410057
[TBL] [Abstract][Full Text] [Related]
17. Endometrial stromal sarcoma of the uterus.
Meden H; Meyer-Rath D; Schauer A; Kuhn W
Anticancer Drugs; 1991 Feb; 2(1):35-7. PubMed ID: 1958850
[TBL] [Abstract][Full Text] [Related]
18. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M
Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
